Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Vries, Elisabeth de"'
Autor:
Heer, Ellen De, Brouwers, Adrienne, Boellaard, Ronald, Sluiter, Wim, Diercks, Gilles, Hospers, Geke, Vries, Elisabeth De, Jalving, Mathilde
Figure S1. Patient selection. Flow diagram showing the selection of eligible patients. (DOCX 547 kb)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::adcaf4acae8999078af46326cb5e13b8
Autor:
Heer, Ellen De, Brouwers, Adrienne, Boellaard, Ronald, Sluiter, Wim, Diercks, Gilles, Hospers, Geke, Vries, Elisabeth De, Jalving, Mathilde
Figure S2. Number of tumour lesions per metastatic location (A) and total MATV (B) per location. In total, 1143 tumour lesions ≥ 1 ml were identified in 64 patients. The outer ring in (A) displays the distribution when lesions
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4dd896c930a014851118a963cfb5b999
Autor:
Heer, Ellen De, Brouwers, Adrienne, Boellaard, Ronald, Sluiter, Wim, Diercks, Gilles, Hospers, Geke, Vries, Elisabeth De, Jalving, Mathilde
Table S1. 18F-FDG PET lesion parameters on a per-lesion basis. (DOCX 14 kb)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::343277726607bd1feaae755cbf60b72a
Autor:
Heer, Ellen De, Brouwers, Adrienne, Boellaard, Ronald, Sluiter, Wim, Diercks, Gilles, Hospers, Geke, Vries, Elisabeth De, Jalving, Mathilde
Figure S4. Kaplan-Meier overall survival estimates stratified by LDH levels and PET parameters. Following baseline 18F-FDG PET/CT scan, 30 patients (46.9%) started with immunotherapy, 20 patients (31.3%) started with BRAF(/MEK) inhibition, and 5 pati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3430873300717549299c35c38ca3d996
Autor:
Heer, Ellen De, Brouwers, Adrienne, Boellaard, Ronald, Sluiter, Wim, Diercks, Gilles, Hospers, Geke, Vries, Elisabeth De, Jalving, Mathilde
Figure S3. Individual tumour lesion SUVpeak (A) and MATV (B) per metastatic location. SUVpeak (A) and MATV (B) of individual lesions ≥ 1 ml (total n = 1143), displayed per metastatic location. Boxes represent interquartile range and whiskers respec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4ad10c219f25d9d1794227a5cb263a0c
Autor:
Bensch, Frederike, Veen, Elly van der, Jorritsma, Annelies, Hooge, Marjolijn Lub-de, Boellaard, Ronald, Oosting, Sjoukje, Schröder, Carolien, Hiltermann, Jeroen, Wekken, Anthonie van der, Groen, Harry, Fine, Bernard, McKnight, Nathan, Bohorquez, Sandra Sanabria, Williams, Simon, Veronese, Luisa, Mancao, Christoph, Brouwers, Adrienne H., Vries, Elisabeth de
Publikováno v:
Cancer Research, CT017-CT017
STARTPAGE=CT017;ENDPAGE=CT017;TITLE=Cancer Research
STARTPAGE=CT017;ENDPAGE=CT017;TITLE=Cancer Research
Proceedings: AACR Annual Meeting 2017; April 1-5, 2017; Washington, DC Background: Programmed death-ligand 1 (PD-L1) expression has been associated with response to PD-1/PD-L1 inhibition, but responses are also seen in patients with PD-L1 negative tu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=narcis______::581e299fecba8085fcfa33eefc9f92eb
https://research.vumc.nl/en/publications/8e4da63d-2004-49b0-b3c6-749d74fac562
https://research.vumc.nl/en/publications/8e4da63d-2004-49b0-b3c6-749d74fac562
Autor:
Bensch, Frederike, Veen, Elly van der, Jorritsma, Annelies, Hooge, Marjolijn Lub-de, Boellaard, Ronald, Oosting, Sjoukje, Schröder, Carolien, Hiltermann, Jeroen, Wekken, Anthonie van der, Groen, Harry, Fine, Bernard, McKnight, Nathan, Bohorquez, Sandra Sanabria, Williams, Simon, Veronese, Luisa, Mancao, Christoph, Brouwers, Adrienne H., Vries, Elisabeth de
Publikováno v:
Bensch, F, Veen, E V D, Jorritsma, A, Hooge, M L, Boellaard, R, Oosting, S, Schröder, C, Hiltermann, J, Wekken, A V D, Groen, H, Fine, B, McKnight, N, Bohorquez, S S, Williams, S, Veronese, L, Mancao, C, Brouwers, A H & Vries, E D 2017, Abstract CT017: First-in-human PET imaging with the PD-L1 antibody 89 Zr-atezolizumab . in Cancer Research . Cancer Research, vol. 77, pp. CT017-CT017 . https://doi.org/10.1158/1538-7445.AM2017-CT017
Proceedings: AACR Annual Meeting 2017; April 1-5, 2017; Washington, DC Background: Programmed death-ligand 1 (PD-L1) expression has been associated with response to PD-1/PD-L1 inhibition, but responses are also seen in patients with PD-L1 negative tu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_____10172::2fb5987218b7bf23b780e8e92ff54aa5
https://research.vumc.nl/en/publications/8e4da63d-2004-49b0-b3c6-749d74fac562
https://research.vumc.nl/en/publications/8e4da63d-2004-49b0-b3c6-749d74fac562